About Fenway
Services
Providers
Providers
The Fenway Institute
Research
Publications
Faculty & Investigators
Community Advisory Board
Population Research Center
Advocacy
Take Action!
Education For Health Professionals
Learning Modules
Resources
Conferences
Education For Consumers
Resources
Events
Ask the Experts About LGBT Health
Calendar
How to Help
Resources
News Room

 

 

SEARCH

 

Username:
Password:
Forgot Password?Register Now

 
tfi educationbanner

Ask the Experts About LGBT Health

Q: Breast Cancer

My partner who is only 42 was diagnosed with a stage 2 breast cancer. She has no family history of breast cancer and we both have gone every year for our screening mammograms since age 40 as our gynecologist recommended. Should we have been doing something more?


A: Response from Dr. Raney

It is difficult to be faced with theses circumstances and my heart goes out to you both. I trust she is receiving advice and treatment from a team of specialists, including an oncologist and breast surgeon, and you and she might also benefit from attending a support group.

Breast cancer occurs in 1 in 68 women in the range of 40 - 49. It occurs even more frequently as we age, and the lifetime risk is approximately 1 in 8. It is the most common cancer of women but is NOT the most frequent cancer associated death (actually lung cancer is the most frequent cause of cancer related death in women.)

So what does it mean that she was diagnosed at Stage 2? Tumors are assigned a stage according to their size at the time of diagnosis and whether there is evidence of having spread (metastasized) to surrounding and distant sites in the body. A stage 1 tumor is localized to the breast and is less than 2 cm (about 1 inch) in size. A stage 2 tumor is at least 2 cm and may have spread to the lymph nodes that drain the affected breast. Stage 3 tumors are 5cm or larger and/or have spread locally and stage 4 tumors have spread to distant sites, at the time of diagnosis.

As far as how well a person will do in treatment, the stage of the tumor helps to predict, but the specific cellular characteristics of the tumor also have a role in determining what the appropriate treatments might be and how well they might work. For example, some tumors have estrogen or progesterone receptors on the surface of the cells that allow these hormones to fuel their growth. Treatment will be directed toward blocking these hormones. Some tumors have a cellular protein referred to as HER-2 which actually accelerates their growth so an agent that blocks this protein, a monoclonal antibody, is used to treat these tumors.

Some tumors are lacking all of these characteristics and they may be more aggressive tumors, known as "triple negative breast tumors. They are rare, but there is a higher incidence in premenopausal African Americans and Latinas. If a tumor is more aggressive it will grow faster during the interval between mammograms and this may be why your partner's tumor was diagnosed at stage 2. Another possibility is that her breasts are very dense and the mammogram did not pick an abnormality until this year for that reason.

Currently we recommend that women begin yearly mammography screening at age 40 or 10 years before the age at which a first degree relative was diagnosed (i.e. mother or sister) which ever comes first. Most women with breast cancer do NOT have a family history of this disease and in fact only 30% of women diagnosed with breast cancer actually do have a family history.

We don't recommend screening younger women because breast cancer is rarer and the increased density of the breasts of younger women interferes with the interpretation of the results. Ultrasound is useful to distinguish solid tissue from a fluid filled cyst when a lump or mammographic shadow is found, but is not a way to screen for cancer in someone with no symptoms. MRI has a host of problems as a screening tool and it isn't clear yet whether this will be better than mammogram.

There are currently no specific tumor markers in the blood that can be screened for.

So what we do recommend is beginning yearly mammograms at age 40 or earlier if there is a family history that mandates this, combined with a yearly breast exam by your primary doctor, and occasional self exams. This way, if a tumor does develop it is likely to be diagnosed at an early stage. This seems to be exactly what you and she were doing, and so the short answer to your question is: no, there was no other screening that you should have been doing. Ask your doctor to discuss your risk factors with you, which may include, use of hormones, alcohol consumption above one drink per day, obesity, and exposure to radiation. There are also risk factors you cannot change such as age of your first period, your first pregnancy, number of pregnancies, whether you breastfed, age of menopause, and family history. Get plenty of exercise, eat a good diet, drink clean water, and keep your weight down.

Download a fact sheet on breast cancer screening

Additional web sites you may want to check out are the Massachusetts Breast Cancer Coalition www.mbcc.org which provides up to date information including information on environmental pollutants that may be contributing to the increasing breast cancer rate, and Dr. Susan Love's site www.dslrf.org which keeps you abreast of the research on diagnosis and treatment.

A: Response from Dr. Raney

UPDATE

On November 16th, 2009 the United States Preventative Services Task Force released new recommendations for screening mammography, which it published in the Annals of Internal Medicine. One of the recommendations was "against routine screening mammography in women aged 40 to 49 years. The decision to start regular, biennial screening mammography before the age of 50 years should be an individual one and take patient context into account, including the patient's values regarding specific benefits and harms. Grade C recommendation."

For the entire list of updated recommendations, please visit: http://www.ahrq.gov/CLINIC/uspstf/uspsbrca.htm

The new recommendations are not without controversy. Currently, Fenway Health has not changed its recommendations or patient protocols as a result of this report. As always, an open conversation with your health care provider is crucial for determining the screening and care that are right for you.

Terms of Use

Please remember that this forum is designed for educational purposes only, and experts are not engaged through this forum in rendering medical, mental health, legal or other professional advice or services. If you have or suspect you may have a medical, mental health, legal or other problem that requires advice, consult your own caregiver, attorney or other qualified professional. Unfortunately, the experts cannot answer every question they receive or diagnose specific health conditions over the internet.

If you are having a medical emergency or otherwise require immediate attention, please call 911 or visit the nearest emergency room.

Experts appearing on this page are independent and are solely responsible for editing and fact-checking their material. Neither Fenway nor any of the collaborating websites at which the experts are carried is the publisher or speaker of posted visitors' questions or the experts' material.

Questions and messages posted to this forum are not statements of advice, opinion, or information of Fenway or any of its collaborating sites. While neither Fenway nor its collaborating sites regularly reviews posted content, we reserve the right to delete, move, or edit postings if we deem it appropriate under the circumstances. Visitors submitting questions remain solely responsible for the content of their messages.

Powered by ExpertViewpoint

Forum Experts

Dr. Makadon

Harvey J. Makadon, MD is Clinical Professor of Medicine at Harvard Medical School and Director of Education and Training at The Fenway Institute at Fenway Health in Boston.  He is a member of the Division of General Medicine at Beth Israel Deaconess Medical Center and is the lead editor of The Fenway Guide to LGBT Health, published by the American College of Physicians in 2007.  He has long been involved in developing both educational and clinical programs to serve gay, lesbian, bisexual and transgender populations.

Dr. Raney

Patricia Raney, MD, is a staff physician at Fenway Health in Boston, Massachusetts. She is a graduate of the University of Massachusetts Medical School and is Board Certified in Family Medicine. Her clinical interests include women's health and wellness, primary care, preventive care and the health concerns of lesbians, bisexual women and transgender people. On a more personal note, she is an avid stone carver.